One such side effect gaining attention is hair loss, prompting many to wonder about the connection between GLP-1 medications and hair health
Key Takeaways Different mechanisms: GLP-1 agonists reduce appetite
A qualified prescribing provider should match the medication and brand to the patients clinical situation, contraindications, treatment goals, and insurance requirements
While these trends are statistically significant and reassuring, the study's authors add a crucial piece of context
Clinicians should consider several potential concerns during evaluation: Unknown active ingredient source Variable potency or concentration Differences in excipients Sterility concerns for injectable products Dosing inaccuracies Limited stability data Inconsistent patient instructions The FDA has also warned healthcare professionals about compounded products made with salt forms of semaglutide that differ from the approved active ingredient
These herbal patches, that are said to reduce appetite and manage weight still have questionable efficacy